Cargando…

Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]

Detalles Bibliográficos
Autores principales: Kuhlin, Johanna, Sturkenboom, Marieke G.G., Ghimire, Samiksha, Margineanu, Ioana, van den Elsen, Simone H.J., Simbar, Noviana, Akkerman, Onno W., Jongedijk, Erwin M., Koster, Remco A., Bruchfeld, Judith, Touw, Daan J., Alffenaar, Jan-Willem C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400071/
https://www.ncbi.nlm.nih.gov/pubmed/36035622
http://dx.doi.org/10.1016/j.jmsacl.2022.08.001
_version_ 1784772669968744448
author Kuhlin, Johanna
Sturkenboom, Marieke G.G.
Ghimire, Samiksha
Margineanu, Ioana
van den Elsen, Simone H.J.
Simbar, Noviana
Akkerman, Onno W.
Jongedijk, Erwin M.
Koster, Remco A.
Bruchfeld, Judith
Touw, Daan J.
Alffenaar, Jan-Willem C.
author_facet Kuhlin, Johanna
Sturkenboom, Marieke G.G.
Ghimire, Samiksha
Margineanu, Ioana
van den Elsen, Simone H.J.
Simbar, Noviana
Akkerman, Onno W.
Jongedijk, Erwin M.
Koster, Remco A.
Bruchfeld, Judith
Touw, Daan J.
Alffenaar, Jan-Willem C.
author_sort Kuhlin, Johanna
collection PubMed
description
format Online
Article
Text
id pubmed-9400071
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94000712022-08-25 Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45] Kuhlin, Johanna Sturkenboom, Marieke G.G. Ghimire, Samiksha Margineanu, Ioana van den Elsen, Simone H.J. Simbar, Noviana Akkerman, Onno W. Jongedijk, Erwin M. Koster, Remco A. Bruchfeld, Judith Touw, Daan J. Alffenaar, Jan-Willem C. J Mass Spectrom Adv Clin Lab Corrigendum Elsevier 2022-08-13 /pmc/articles/PMC9400071/ /pubmed/36035622 http://dx.doi.org/10.1016/j.jmsacl.2022.08.001 Text en © 2022 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Kuhlin, Johanna
Sturkenboom, Marieke G.G.
Ghimire, Samiksha
Margineanu, Ioana
van den Elsen, Simone H.J.
Simbar, Noviana
Akkerman, Onno W.
Jongedijk, Erwin M.
Koster, Remco A.
Bruchfeld, Judith
Touw, Daan J.
Alffenaar, Jan-Willem C.
Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
title Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
title_full Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
title_fullStr Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
title_full_unstemmed Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
title_short Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]
title_sort corrigendum to “mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [clin. mass spectrom. 14(part a) (2019) 34–45]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400071/
https://www.ncbi.nlm.nih.gov/pubmed/36035622
http://dx.doi.org/10.1016/j.jmsacl.2022.08.001
work_keys_str_mv AT kuhlinjohanna corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT sturkenboommariekegg corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT ghimiresamiksha corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT margineanuioana corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT vandenelsensimonehj corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT simbarnoviana corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT akkermanonnow corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT jongedijkerwinm corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT kosterremcoa corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT bruchfeldjudith corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT touwdaanj corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445
AT alffenaarjanwillemc corrigendumtomassspectrometryfortherapeuticdrugmonitoringofantituberculosisdrugsclinmassspectrom14parta20193445